Is pentraxin-3 stronger than C-reactive protein to determine inflammation in peritoneal dialysis patients?
European Journal of Inflammation, cilt.10, sa.3, ss.289-295, 2012 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 3
- Basım Tarihi: 2012
- Doi Numarası: 10.1177/1721727x1201000305
- Dergi Adı: European Journal of Inflammation
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.289-295
- Anahtar Kelimeler: atherosclerosis, endothelial dysfunction, inflammation, pentraxin-3, peritoneal dialysis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Pentraxin-3 (PTX-3) is the prototype of long pentraxins and is produced by many tissues and organs including vascular endothelial cells in response to pro-inflammatory signals. It is thought to be an independent indicator of disease activity. We analyzed the correlation of PTX-3 with other markers of inflammation in peritoneal dialysis (PD) patients. Non-diabetic patients on chronic PD program who meet the dialysis adequacy criteria and who had no active infectious/inflammatory disease were included. Demographic and clinical parameters were recorded as well as hsCRP, fibrinogen, interleukin-6 (IL-6) and PTX-3 levels; and the correlation between them were studied. Twenty-five patients (mean age: 45.7±12.5 years; female/male ratio: 16/9) were included. Mean PTX-3 level was 2.16±2.76ng/ml. PTX-3 was found to be correlated positively with only IL-6 among inflammatory markers (r=0.827; p<0.001) but not with hsCRP. With linear regression model, IL-6 was the only independent determinant of PTX-3 levels. PTX-3 may be a more valuable marker of inflammation than CRP in patients on PD. Copyright © by BIOLIFE, s.a.s.